(redirected from Refusal to File)
Category filter:
RTFRich Text Format
RTFReady To Fly (prebuilt R/C planes)
RTFReport to Follow (law enforcement)
RTFReturn To Force (military term for aircraft return home)
RTFRequest the Floor (multi-person online chats)
RTFReturn To Flight
RTFReturn the Flag (gaming)
RTFRewrite the Future (education project)
RTFRevision Task Force
RTFResearch Training Fellowship (various locations)
RTFResidential Treatment Facility
RTFRigid Thermofoil (home improvement, laminate or veneer)
RTFReturn to Factory
RTFResponse to Forecast
RTFRadio Television Film
RTFReturn the Favor
RTFRealtek Fast Ethernet
RTFRich Text Field
RTFRealty Transfer Fee (New Jersey)
RTFReal Time Factor (metric)
RTFReturn to Floor
RTFReady to Feed (baby formula)
RTFResponse Task Force
RTFReconstruction Task Force (various locations)
RTFReady to Fight (band)
RTFResearch and Testing Facility (Cold Climate Housing Research Center)
RTFRadiodiffusion-Télévision Française (French broadcasting company; est. 1949)
RTFRegional Task Force
RTFRestoring the Foundations (Hendersonville, NC)
RTFReady To Fire
RTFReal-Time Feedback
RTFResearch Triangle Foundation (North Carolina)
RTFRefusal to File
RTFRead The Form
RTFResistance Transfer Factor
RTFRun-Time Fault (computing)
RTFRecovery Task Force
RTFRag-Tag Fleet (sci-fi, Battlestar Galactica)
RTFRecommend to Friends
RTFRadiation Therapy Facility
RTFRadio Terminal Function
RTFRaks Thai Foundation
RTFReturns Transaction File
RTFReduce to Fit (Kinko's)
RTFRealignment Task Force
RTFRadar Terrain Following
RTFRadio Télévison Française
RTFReady Training Folder
RTFRegulatory Time Frame
RTFRelease To the Fleet
RTFRound Trip Flow (Ixia Communications)
RTFRoads & Transport Forum
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
(a) The failure or refusal to file an Annual Report;
Gone was the option of obtaining the three letters of refusal to file an ethics complaint.
The Type A meeting was conducted to review the two issues identified in the Refusal to File letter issued by the FDA on April 5, 2019: first, certain non-clinical studies were not submitted to allow assessment of the chronic administration of fenfluramine; and, second, the application contained an incorrect version of a clinical dataset.
The firm has received a refusal to file letter from The US FDA regarding its new drug application for the product.
His refusal to file a COC even sparked a social media trend Kalbo Para sa Pagbabago led by Duterte's daughter Sara Duterte-Carpio, who went bald in convincing her father to run.
William Blair analyst Tim Lugo lowered his fair value estimate for Zogenix to $57 and concedes the stock will likely remain weak in the near following Fintepla's refusal to file letter from the FDA.
The resubmission addressed the two issues raised in the recent Refusal to File letter and included all additional information requested by the FDA in that letter.
Morgan Stanley analyst David Lebowitz said he expects shares of GW Pharmaceuticals (GWPH) to be up at least 5-10% on the open following news that Zogenix (ZGNX) was issued a Refusal to File letter for Fintepla by the FDA.
Catalyst Pharmaceuticals Inc (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercialising innovative therapies for people with rare debilitating diseases, announced yesterday that it has received a 'Refusal to File' letter from the US Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Firdapse(R) (amifampridine phosphate).
Previously, on February 27, 2018, Celgene had announced that it has received a Refusal to File letter from the FDA regarding its New Drug Application for ozanimod in development for the treatment of patients with relapsing forms of multiple sclerosis as the FDA determined that the nonclinical and clinical pharmacology sections in the NDA were insufficient to permit a complete review.
This resubmission follows the FDA's July 2011 Refusal to File letter in which the agency requested reformatting and reanalyses of some datasets in the dossier.
FDA's acceptance of the ALKS 5461 NDA and rescission of the refusal to file letter issued March 30, follows productive interactions with the Agency in which Alkermes clarified certain aspects of the NDA submission.